The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Albumin as a versatile platform for drug half-life extension
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Curry, S., Mandelkow, H., Brick, P., & Franks, N. (1998) · Nature Structural Biology · doi:10.1038/1869 · Cited by 1,377
Properties of the Glomerular Barrier and Mechanisms of Proteinuria
Haraldsson, B., Nyström, J., & Deen, W. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00055.2006 · Cited by 909
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
An Fc receptor structurally related to MHC class I antigens
Simister, N. E., & Mostov, K. E. (1989) · Nature · doi:10.1038/337184a0 · Cited by 729
Junghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
Enhanced antibody half-life improves in vivo activity
Zalevsky, J., Chamberlain, A. K., Horton, H. M., Karki, S., Leung, I. W. L., Sproule, T. J., Lazar, G. A., Roopenian, D. C., & Desjarlais, J. R. (2010) · Nature Biotechnology · doi:10.1038/nbt.1601 · Cited by 653
Chaudhury, C., Mehnaz, S., Robinson, J. M., Hayton, W. L., Pearl, D. K., Roopenian, D. C., & Anderson, C. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021829 · Cited by 640
Strategies for extended serum half-life of protein therapeutics
Kontermann, R. E. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.012 · Cited by 573
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
Dennis, M. S., Zhang, M., Meng, Y. G., Kadkhodayan, M., Kirchhofer, D., Combs, D., & Damico, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205854200 · Cited by 508
Ober, R. J., Radu, C. G., Ghetie, V., & Ward, E. S. (2001) · International Immunology · doi:10.1093/intimm/13.12.1551 · Cited by 501
Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice
Ghetie, V., Hubbard, J. G., Kim, J., Tsen, M., Lee, Y., & Ward, E. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260327 · Cited by 469
Crystal structure of the complex of rat neonatal Fc receptor with Fc
Burmeister, W. P., Huber, A. H., & Bjorkman, P. J. (1994) · Nature · doi:10.1038/372379a0 · Cited by 431
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Ahrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 419
Crystal structure of the complex of rat neonatal Fc receptor with Fc
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90005-5 · Cited by 381
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Roovers, R. C., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A. J., Revets, H., de Haard, H. J., & van Bergen en Henegouwen, P. M. P. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0180-4 · Cited by 346
Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor
Burmeister, W. P., Gastinel, L. N., Simister, N. E., Blum, M. L., & Bjorkman, P. J. (1994) · Nature · doi:10.1038/372336a0 · Cited by 337
Schnitzer, J. E., & Oh, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37571-3 · Cited by 324
Tijink, B. M., Laeremans, T., Budde, M., Walsum, M. S.-V., Dreier, T., de Haard, H. J., Leemans, C. R., & van Dongen, G. A. M. S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2384 · Cited by 305
Albumin Binding to FcRn: Distinct from the FcRn−IgG Interaction
Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., & Anderson, C. L. (2006) · Biochemistry · doi:10.1021/bi052628y · Cited by 290
An Engineered Human IgG1 Antibody with Longer Serum Half-Life
Hinton, P. R., Xiong, J. M., Johlfs, M. G., Tang, M. T., Keller, S., & Tsurushita, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.346 · Cited by 282
McDonagh, C. F., Huhalov, A., Harms, B. D., Adams, S., Paragas, V., Oyama, S., Zhang, B., Luus, L., Overland, R., Nguyen, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0820 · Cited by 278
RENAL TUBULE ALBUMIN TRANSPORT
Gekle, M. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.031103.154845 · Cited by 265
pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat.
Rodewald, R. (1976) · The Journal of cell biology · doi:10.1083/jcb.71.2.666 · Cited by 264
From good old biochemical analyses to high-throughput omics measurements and back
Heinemann, M., & Sauer, U. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.12.002 · Cited by 263
West, A. P., & Bjorkman, P. J. (2000) · Biochemistry · doi:10.1021/bi000749m · Cited by 257
Engineering of a femtomolar affinity binding protein to human serum albumin
Jonsson, A., Dogan, J., Herne, N., Abrahmsen, L., & Nygren, P.-A. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzn028 · Cited by 242
Adnectins: engineered target-binding protein therapeutics
Lipovsek, D. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq097 · Cited by 242
Increasing the serum persistence of an IgG fragment by random mutagenesis
Ghetie, V., Popov, S., Borvak, J., Radu, C., Matesoi, D., Medesan, C., Ober, R. J., & Ward, E. S. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-637 · Cited by 241
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes
Rosenstock, J., Reusch, J., Bush, M., Yang, F., Stewart, M., & for the Albiglutide Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0366 · Cited by 237
Receptor-mediated endocytosis in renal proximal tubule
Christensen, E. I., Verroust, P. J., & Nielsen, R. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0685-8 · Cited by 231
Müller, D., Karle, A., Meißburger, B., Höfig, I., Stork, R., & Kontermann, R. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700820200 · Cited by 222
Albinterferon α-2b: a genetic fusion protein for the treatment of chronic hepatitis C
Subramanian, G. M., Fiscella, M., Lamousé-Smith, A., Zeuzem, S., & McHutchison, J. G. (2007) · Nature Biotechnology · doi:10.1038/nbt1364 · Cited by 216
Montoyo, H. P., Vaccaro, C., Hafner, M., Ober, R. J., Mueller, W., & Ward, E. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810796106 · Cited by 211
Perspective – FcRn transports albumin: relevance to immunology and medicine
Anderson, C. L., Chaudhury, C., Kim, J., Bronson, C. L., Wani, M. A., & Mohanty, S. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.05.004 · Cited by 209
Kim, J., Hayton, W. L., Robinson, J. M., & Anderson, C. L. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.09.001 · Cited by 208
Minshall, R. D., Tiruppathi, C., Vogel, S. M., & Malik, A. B. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0367-x · Cited by 203
Madsbad, S., Kielgast, U., Asmar, M., Deacon, C. F., Torekov, S. S., & Holst, J. J. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01357.x · Cited by 202
Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
Andersen, J. T., Dalhus, B., Cameron, J., Daba, M. B., Plumridge, A., Evans, L., Brennan, S. O., Gunnarsen, K. S., Bjørås, M., Sleep, D., et al. (2012) · Nature Communications · doi:10.1038/ncomms1607 · Cited by 199
Self-citationTerje Andersen, J., Bekele Daba, M., Berntzen, G., Michaelsen, T. E., & Sandlie, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081828 · Cited by 197
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
Holt, L. J., Basran, A., Jones, K., Chorlton, J., Jespers, L. S., Brewis, N. D., & Tomlinson, I. M. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm067 · Cited by 193
Chapter 4 Multitasking by Exploitation of Intracellular Transport Functions
Ward, E. S., & Ober, R. J. (2009) · Advances in immunology · doi:10.1016/s0065-2776(09)03004-1 · Cited by 177
Andersen, J. T., Pehrson, R., Tolmachev, V., Daba, M. B., Abrahmsén, L., & Ekblad, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164848 · Cited by 177
Santagostino, E., Negrier, C., Klamroth, R., Tiede, A., Pabinger-Fasching, I., Voigt, C., Jacobs, I., & Morfini, M. (2012) · Blood · doi:10.1182/blood-2012-05-429688 · Cited by 176
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1
Medesan, C., Matesoi, D., Radu, C., Ghetie, V, & Ward, E. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2211 · Cited by 175
Wani, M. A., Haynes, L. D., Kim, J., Bronson, C. L., Chaudhury, C., Mohanty, S., Waldmann, T. A., Robinson, J. M., & Anderson, C. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600548103 · Cited by 162
Genetic fusion to albumin improves the pharmacokinetic properties of factor IX
Weimer, T., Kronthaler, U., Lang, W., Schulte, S., & Metzner, H. J. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-04-0255 · Cited by 159
Nakajou, K., Watanabe, H., Kragh‐Hansen, U., Maruyama, T., & Otagiri, M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2003.08.001 · Cited by 158
Schnitzer, J. E., & Bravo, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53212-9 · Cited by 155
Schnitzer, J. E., Sung, A. W., Horvat, R., & Bravo, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35799-5 · Cited by 152
Kim, J., Bronson, C. L., Hayton, W. L., Radmacher, M. D., Roopenian, D. C., Robinson, J. M., & Anderson, C. L. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00286.2005 · Cited by 145
Insulin detemir: from concept to clinical experience
Home, P., & Kurtzhals, P. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.3.325 · Cited by 143
Osborn, B. L., Sekut, L., Corcoran, M. L., Poortman, C., Sturm, B. L., Chen, G., Mather, D., Lin, H. L., & Parry, T. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02644-4 · Cited by 141
Nguyen, A., Reyes, A. E., Zhang, M., McDonald, P., Wong, W., Damico, L. A., & Dennis, M. S. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl011 · Cited by 141
Baggio, L. L., Huang, Q., Cao, X., & Drucker, D. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.017 · Cited by 137
Andersen, J. T., Qian, J. D., & Sandlie, I. (2006) · European Journal of Immunology · doi:10.1002/eji.200636556 · Cited by 135
Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium
Predescu, D. N., & Palade, G. E. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.2.h725 · Cited by 135
Renal FcRn Reclaims Albumin but Facilitates Elimination of IgG
Sarav, M., Wang, Y., Hack, B. K., Chang, A., Jensen, M. A., Bao, L., & Quigg, R. J. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008090976 · Cited by 134
Andersen, J. T., & Sandlie, I. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.318 · Cited by 130
Development of a Long-Acting Insulin Analog Using Albumin Fusion Technology
Duttaroy, A., Kanakaraj, P., Osborn, B. L., Schneider, H., Pickeral, O. K., Chen, C., Zhang, G., Kaithamana, S., Singh, M., Schulingkamp, R. J., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.251 · Cited by 129
Identification of albumin-binding proteins in capillary endothelial cells.
Ghinea, N., Fixman, A., Alexandru, D., Popov, D., Hasu, M., Ghitescu, L. D., Eskenasy, M., Simionescu, M., & Simionescu, M. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.1.231 · Cited by 117
Melder, R. J., Osborn, B. L., Riccobene, T. A., Kanakaraj, P., Wei, P., Chen, G., Stolow, D. T., Halpern, W., Migone, T., Wang, Q., et al. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0624-7 · Cited by 113
Tubular toxicity of proteinuria
Baines, R. J., & Brunskill, N. J. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.174 · Cited by 111
Waldmann, T. A., & Terry, W. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114947 · Cited by 107
Prolonged in Vivo Residence Times of Antibody Fragments Associated with Albumin
Smith, B. J., Popplewell, A. G., Athwal, D., Chapman, A. P., Heywood, S. P., West, S. M., Carrington, B., Nesbitt, A. M., Lawson, A. D. G., Antoniw, P., et al. (2001) · Bioconjugate Chemistry · doi:10.1021/bc010003g · Cited by 105
Prolonged in-vivo half-life of factor VIIa by fusion to albumin
Weimer, T., Wormsbächer, W., Kronthaler, U. O., Lang, W., Liebing, U., & Schulte, S. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0525 · Cited by 102
Gastinel, L. N., Simister, N. E., & Björkman, P. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.638 · Cited by 98
New Strategy for the Extension of the Serum Half-Life of Antibody Fragments
Trüssel, S., Dumelin, C. E., Frey, K., Villa, A., Buller, F., & Neri, D. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9002772 · Cited by 98
Halpern, W., Riccobene, T. A., Agostini, H., Baker, K., Stolow, D. T., Gu, M., Hirsch, J., Mahoney, A., Carrell, J. A., Boyd, E., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1020917732218 · Cited by 91
Biodistribution and tumor imaging of an anti-CEA single-chain antibody–albumin fusion protein
Yazaki, P. J., Kassa, T., Cheung, C. W., Crow, D. M., Sherman, M. A., Bading, J. R., Anderson, A.-L. J., Colcher, D. M., & Raubitschek, A. A. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.10.010 · Cited by 76
Sung, C., Nardelli, B., LaFleur, D. W., Blatter, E. E., Corcoran, M. L., Olsen, H. S., Birse, C. E., Pickeral, O. K., Zhang, J., Shah, D., et al. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900360520423 · Cited by 71
Wang, W. Q., Ou, Y. C., & Shi, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048203.30568.81 · Cited by 70
Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor
Stoddart, C. A., Nault, G., Galkina, S. A., Thibaudeau, K., Bakis, P., Bousquet-Gagnon, N., Robitaille, M., Bellomo, M., Paradis, V., Liscourt, P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805536200 · Cited by 65
Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7–36) analog
Léger, R., Thibaudeau, K., Robitaille, M., Quraishi, O., van Wyk, P., Bousquet-Gagnon, N., Carette, J., Castaigne, J., & Bridon, D. P. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.066 · Cited by 63
Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin
Bosse, D., Praus, M., Kiessling, P. C., Nyman, L., Andresen, C., Waters, J., & Schindel, F. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004269646 · Cited by 61
Huang, Y., Lundy, P. M., Lazaris, A., Huang, Y., Baldassarre, H., Wang, B., Turcotte, C., Côté, M., Bellemare, A., Bilodeau, A. S., et al. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-50 · Cited by 60
Oxidation of Arg‐410 promotes the elimination of human serum albumin
Iwao, Y., Anraku, M., Yamasaki, K., Kragh-Hansen, U., Kawai, K., Maruyama, T., & Otagiri, M. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.01.011 · Cited by 53
A human serum albumin–thioredoxin fusion protein prevents experimental contrast-induced nephropathy
Kodama, A., Watanabe, H., Tanaka, R., Tanaka, H., Chuang, V. T. G., Miyamoto, Y., Wu, Q., Endo, M., Hamasaki, K., Ishima, Y., et al. (2013) · Kidney International · doi:10.1038/ki.2012.429 · Cited by 48
Synthesis and Evaluation of Insulin−Human Serum Albumin Conjugates
Thibaudeau, K., Léger, R., Huang, X., Robitaille, M., Quraishi, O., Soucy, C., Bousquet-Gagnon, N., van Wyk, P., Paradis, V., Castaigne, J., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050102k · Cited by 47
Ikuta, S., Chuang, V. T. G., Ishima, Y., Nakajou, K., Furukawa, M., Watanabe, H., Maruyama, T., & Otagiri, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.020 · Cited by 45
Joung, C.-H., Shin, J.-Y., Koo, J.-K., Lim, J. J., Wang, J.-S., Lee, S.-J., Tan, H.-K., Kim, S.-L., & Lim, S. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2009.07.003 · Cited by 43
Mezo, A. R., Sridhar, V., Badger, J., Sakorafas, P., & Nienaber, V. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.120667 · Cited by 43
Tuning the serum persistence of human serum albumin domain III:diabody fusion proteins
Kenanova, V. E., Olafsen, T., Salazar, F. B., Williams, L. E., Knowles, S. M., & Wu, A. M. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq054 · Cited by 42
Giannoukakis, N. (2003) · PubMed · Cited by 40
Evans, L. R., Hughes, M., Waters, J., Cameron, J., Dodsworth, N., Tooth, D., Greenfield, A., & Sleep, D. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.05.009 · Cited by 40
Self-citationNolte, M. W., Nichols, T. C., Mueller‐Cohrs, J., Merricks, E. P., Pragst, I., Zollner, S., & Dickneite, G. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04826.x · Cited by 39
FcRn binding properties of an abnormal truncated analbuminemic albumin variant
Andersen, J. T., Daba, M. B., & Sandlie, I. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.12.001 · Cited by 36
Andersen, J. T., Foss, S., Kenanova, V. E., Olafsen, T., Leikfoss, I. S., Roopenian, D. C., Wu, A. M., & Sandlie, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355131 · Cited by 35
Tanaka, R., Watanabe, H., Kodama, A., Chuang, V. T. G., Ishima, Y., Hamasaki, K., Tanaka, K., Mizushima, T., Otagiri, M., & Maruyama, T. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201814 · Cited by 32
Modulation of Clearance of Recombinant Serum Albumin by Either Glycosylation or Truncation
Sheffield, W. P., Marques, J. A., Bhakta, V., & Smith, I. J. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00286-3 · Cited by 30
Selective Domain Stabilization as a Strategy to Reduce Fusion Protein Aggregation
Cordes, A. A., Platt, C. W., Carpenter, J. F., & Randolph, T. W. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23049 · Cited by 27
Gut-Derived Incretin Hormones and New Therapeutic Approaches
Bloomgarden, Z. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2554 · Cited by 27
Iwao, Y., Hiraike, M., Kragh‐Hansen, U., Mera, K., Noguchi, T., Anraku, M., Kawai, K., Maruyama, T., & Otagiri, M. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.09.001 · Cited by 24
Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin
Iwao, Y., Hiraike, M., Kragh‐Hansen, U., Kawai, K., Suenaga, A., Maruyama, T., & Otagiri, M. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.022 · Cited by 19
Cordes, A. A., Carpenter, J. F., & Randolph, T. W. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23118 · Cited by 16
Herring, C., & Schön, O. (2012) · Wiley eBooks · doi:10.1002/9783527644827.ch13 · Cited by 5
Cited by
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
The making of bispecific antibodies
Brinkmann, U., & Kontermann, R. E. (2017) · mAbs · doi:10.1080/19420862.2016.1268307 · Cited by 923
Albumin-based drug delivery: harnessing nature to cure disease
Larsen, M. T., Kuhlmann, M., Hvam, M. L., & Howard, K. A. (2016) · Molecular and Cellular Therapies · doi:10.1186/s40591-016-0048-8 · Cited by 683
Harnessing albumin as a carrier for cancer therapies
Hoogenboezem, E. N., & Duvall, C. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.011 · Cited by 610
Metadata
- Authors
- Sleep, D., Cameron, J., & Evans, L. R.
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 1830
- Issue
- 12
- Pages
- 5526-5534
- ISSN
- 0304-4165 (ISSN-L)
- OpenAlex
- W2035776098
- Cited by
- 485
- References
- 97
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.